The global demulcent eye drops market has seen significant growth over the past few years, with a surge in demand for eye care products due to increasing eye-related problems. With the rise in the number of people suffering from eye diseases and discomfort, the demand for eye drops has increased. Key players in the market are focusing on product innovation and expansion strategies to cater to the growing demand and strengthen their position in the market.
One of the key strategies employed by players in the demulcent eye drops market is the introduction of innovative products. For instance, in 2021, Alcon, a subsidiary of Novartis AG, introduced Systane Hydration Preservative-Free Eye Drops, a new product in its Systane range of eye drops. This product provides long-lasting relief to people with dry eyes and is preservative-free, making it suitable for individuals with sensitive eyes. Similarly, in 2020, Allergan, a subsidiary of AbbVie, introduced Refresh Relieva PF, a new product in its Refresh range of eye drops. This product provides a unique blend of ingredients that help to hydrate and protect the eyes, making it suitable for people with dry and irritated eyes.
Another key strategy employed by players in the demulcent eye drops market is expansion into new markets. For instance, in 2020, Bausch + Lomb, a subsidiary of Bausch Health Companies, Inc., announced the expansion of its Biotrue range of eye drops in Canada. This expansion will help the company to cater to the growing demand for eye drops in the Canadian market and strengthen its position in the region. Similarly, in 2019, Novartis AG expanded its Systane range of eye drops in India to cater to the growing demand for eye care products in the country.
Apart from product innovation and expansion strategies, players in the demulcent eye drops market are also focusing on mergers and acquisitions to strengthen their position in the market. For instance, in 2019, Bausch Health Companies, Inc. acquired certain assets of Synergy Pharmaceuticals, a company focused on developing therapies for gastrointestinal diseases. This acquisition helped Bausch Health Companies to expand its product portfolio and strengthen its position in the global demulcent eye drops market. Similarly, in 2021, CooperVision, a subsidiary of The Cooper Companies, Inc., announced the acquisition of No7 Contact Lenses, a company focused on developing contact lenses. This acquisition will help CooperVision to expand its product portfolio and strengthen its position in the global eye care market.
In conclusion, the demulcent eye drops market is witnessing significant growth, and key players in the market are focusing on product innovation and expansion strategies to cater to the growing demand for eye care products. With the rise in the number of people suffering from eye-related problems, there is a growing need for effective and safe eye care products. Players in the market are also focusing on mergers and acquisitions to strengthen their position in the market. With the increasing focus on eye care and the introduction of innovative products, the demulcent eye drops market is expected to witness continued growth in the coming years.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Everest Market Insights journalist was involved in the writing and production of this article.
